Andrew David Badley, MD

Professor, Rochester, MN, Infectious Diseases

EmailBadley.Andrew@mayo.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Andrew David Badley is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

6 Finished

Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.
Badley, A. D.
National Institute of Allergy and Infectious Diseases
6/15/15 → 5/31/20
Project: Research project
Prime shock and kill for HIV erradication
Badley, A. D. & Kinney, L.
National Institute of Allergy and Infectious Diseases
2/15/14 → 1/31/19
Project: Research project
Enhancing control of HIV by inhibiting TRAILshort
Badley, A. D. & Kinney, L.
National Institute of Allergy and Infectious Diseases
7/2/13 → 6/1/15
Project: Research project
Procaspase 8 Activation by HIV Protease
Badley, A. D. & Kinney, L.
National Institute of Allergy and Infectious Diseases
5/1/04 → 4/30/09
Project: Research project
Significance of HIV Protease Cleavage of Procaspase 8
Badley, A. D.
National Institute of Allergy and Infectious Diseases
9/1/03 → 8/31/04
Project: Research project

5342 Citations
42 Scopus h-Index
121 Article
19 Review article
5 Letter
4 Short survey
More

Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients
Pawlowski, C., Venkatakrishnan, A. J., Kirkup, C., Berner, G., Puranik, A., O'Horo, J. C., Badley, A. D. & Soundararajan, V., Mar 2021, In: EClinicalMedicine. 33, 100774.
Research output: Contribution to journal › Article › peer-review

Open Access
Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
Pawlowski, C., Puranik, A., Bandi, H., Venkatakrishnan, A. J., Agarwal, V., Kennedy, R., O’Horo, J. C., Gores, G. J., Williams, A. W., Halamka, J., Badley, A. D. & Soundararajan, V., Dec 2021, In: Scientific reports. 11, 1, 4741.
Research output: Contribution to journal › Article › peer-review

Open Access
Healthcare disparities among anticoagulation therapies for severe COVID-19 patients in the multi-site VIRUS registry
Kirkup, C., Pawlowski, C., Puranik, A., Conrad, I., O'Horo, J. C., Gomaa, D., Banner-Goodspeed, V. M., Mosier, J. M., Zabolotskikh, I. B., Daugherty, S. K., Bernstein, M. A., Zaren, H. A., Bansal, V., Pickering, B., Badley, A. D., Kashyap, R., Venkatakrishnan, A. J. & Soundararajan, V., 2021, (Accepted/In press) In: Journal of medical virology.
Research output: Contribution to journal › Article › peer-review

Open Access
Human cancers express TRAILshort, a dominant negative TRAIL splice variant, which impairs immune effector cell killing of tumor cells
Aboulnasr, F., Krogman, A., Graham, R. P., Cummins, N. W., Misra, A., Garcia-Rivera, E., Anderson, J. R., Natesampillai, S., Kogan, N., Aravamudan, M., Nie, Z., Chung, T. D. Y., Buick, R., Feldman, A. L., King, R. L., Novak, A. J., Ansell, S. M., Kenderian, S. & Badley, A. D., Nov 1 2021, In: Clinical Cancer Research. 26, 21, p. 5759-5771 13 p.
Research output: Contribution to journal › Article › peer-review
2 Scopus citations
In Reply — Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019
Temesgen, Z., Kenderian, S. S. & Badley, A. D., Mar 2021, In: Mayo Clinic proceedings. 96, 3, p. 817-818 2 p.
Research output: Contribution to journal › Letter › peer-review

Open Access